Edwards Lifesciences Corporation Finite-Lived Intangible Assets, Net
Edwards Lifesciences Corporation (EW) had Finite-Lived Intangible Assets, Net of $617.70 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-02-25
- 2025-12-31: Finite-Lived Intangible Assets, Net $617.70M.
- 2024-12-31: Finite-Lived Intangible Assets, Net $666.10M.
- 2023-12-31: Finite-Lived Intangible Assets, Net $141.80M; Finite-Lived Intangible Assets, Net as first filed $170.80M.
- 2022-12-31: Finite-Lived Intangible Assets, Net $95.20M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2025-12-31 | $617.70M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $666.10M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $141.80M 10-K · filed 2025-02-28 | $170.80M 10-K · filed 2024-02-12 |
| 2022-12-31 | $95.20M 10-K · filed 2024-02-12 | |
| 2021-12-31 | $105.50M 10-K · filed 2023-02-13 | |
| 2020-12-31 | $113.30M 10-K · filed 2022-02-14 | |
| 2019-12-31 | $118.40M 10-K · filed 2021-02-12 | |
| 2018-12-31 | $80.20M 10-K · filed 2020-02-14 | |
| 2017-12-31 | $152.70M 10-K · filed 2019-02-15 | |
| 2016-12-31 | $14.80M 10-K · filed 2018-02-16 | |
| 2015-12-31 | $15.40M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $23.40M 10-K · filed 2016-02-19 | |
| 2014-09-30 | $25.80M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $29.50M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $27.00M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $28.90M 10-K · filed 2015-02-20 | $52.60M 10-K · filed 2014-02-28 |
| 2013-09-30 | $51.90M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $53.70M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $54.80M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $56.00M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $53.30M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $55.40M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $58.80M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $60.60M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $63.90M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $66.60M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $70.00M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $67.10M 10-K · filed 2012-02-27 | |
| 2009-12-31 | $86.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |